Between promise and responsibility: What makes a good health app

5. Aug 2026 | B2B

Quality criteria between evidence, data quality, and sustainable patient access Health apps have long been part of strategic initiatives in pharmaceutical companies. Today, the question is no longer whether they are used, but which applications actually provide robust...

Staying healthy in everyday life: Small changes with a big impact

14. Jul 2026 | Live healthier

Health does not have to be perfect For many people, living healthier sounds like strict meal plans, intensive exercise programs, or a completely new daily routine. But this very idea can quickly become overwhelming. Scientific findings have long shown that health...

Direct-To-Patient (d2p) in the Pharmaceutical Industry: Between Regulatory Boundaries and Strategic Necessity

1. Jul 2026 | B2B, B2B_Patient_Engagement

How can pharmaceutical companies reach patients directly without taking regulatory risks or losing relevance? This question shapes the current discussion around direct-to-patient approaches. While direct patient communication has been established in the USA for...

Preventive checkups: Why early detection is so important

23. Jun 2026 | Live healthier, Patient rights

Many diseases develop unnoticed over the course of years. Since symptoms are often absent at first or only mild, even serious diseases frequently remain undetected for a long time. This is where preventive checkups come in: They systematically help to detect certain...

Guidelines and Real-World Care: Why Evidence-Based Lipid Therapy Often Fails in Everyday Practice

3. Jun 2026 | B2B_Patient_Engagement

Cardiovascular guidelines are considered the gold standard of evidence-based medicine. The recommendations of the European Society of Cardiology and the European Atherosclerosis Society for lowering LDL cholesterol are clear, differentiated by risk profiles, and...